After liver transplant for HCV, better antiviral results with cyclosporine
NEW YORK (Reuters Health) - In patients transplanted for hepatitis C cirrhosis, the virus inevitably recurs. Now a new meta-analysis suggests that cyclosporine-based immunosuppression may be associated with a better response to antiviral therapy after transplant than tacrolimus-based protocols. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news

UPDATE: After liver transplant for HCV, better antiviral results with cyclosporine
NEW YORK (Reuters Health) - In patients transplanted for hepatitis C cirrhosis, the virus inevitably recurs. Now a new meta-analysis suggests that cyclosporine-based immunosuppression may be associated with a better response to antiviral therapy after transplant than tacrolimus-based protocols. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news